Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$73.27 - $83.09 $293 - $332
4 Added 0.36%
1,114 $90,000
Q3 2023

Nov 01, 2023

BUY
$73.94 - $80.67 $369 - $403
5 Added 0.45%
1,110 $83,000
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $22,422 - $25,576
-295 Reduced 21.07%
1,105 $85,000
Q1 2023

Apr 13, 2023

SELL
$77.31 - $88.08 $9,354 - $10,657
-121 Reduced 7.96%
1,400 $116,000
Q4 2022

Jan 13, 2023

BUY
$62.32 - $89.47 $249 - $357
4 Added 0.26%
1,521 $0
Q3 2022

Oct 20, 2022

BUY
$59.54 - $68.01 $297 - $340
5 Added 0.33%
1,517 $94,000
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $692 - $780
-12 Reduced 0.79%
1,512 $93,000
Q1 2022

Apr 29, 2022

BUY
$57.92 - $72.58 $347 - $435
6 Added 0.4%
1,524 $91,000
Q4 2021

Jan 31, 2022

SELL
$64.88 - $73.64 $5,709 - $6,480
-88 Reduced 5.48%
1,518 $110,000
Q3 2021

Oct 12, 2021

BUY
$67.69 - $73.03 $1,556 - $1,679
23 Added 1.45%
1,606 $112,000
Q2 2021

Jul 15, 2021

BUY
$63.47 - $69.35 $380 - $416
6 Added 0.38%
1,583 $109,000
Q1 2021

May 03, 2021

SELL
$60.0 - $68.46 $5,760 - $6,572
-96 Reduced 5.74%
1,577 $102,000
Q4 2020

Feb 03, 2021

BUY
$56.65 - $64.55 $19,374 - $22,076
342 Added 25.69%
1,673 $97,000
Q3 2020

Oct 19, 2020

SELL
$62.1 - $78.08 $7,017 - $8,823
-113 Reduced 7.83%
1,331 $84,000
Q2 2020

Jul 24, 2020

BUY
$72.34 - $84.0 $32,842 - $38,136
454 Added 45.86%
1,444 $111,000
Q1 2020

May 06, 2020

SELL
$62.63 - $80.22 $23,235 - $29,761
-371 Reduced 27.26%
990 $74,000
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $21,505 - $23,655
-349 Reduced 20.41%
1,361 $88,000
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $2,875 - $3,174
-46 Reduced 2.62%
1,710 $108,000
Q2 2019

Jul 19, 2019

SELL
$61.87 - $69.38 $139,702 - $156,660
-2,258 Reduced 56.25%
1,756 $118,000
Q1 2019

May 03, 2019

SELL
$62.53 - $70.05 $409,884 - $459,177
-6,555 Reduced 62.02%
4,014 $261,000
Q4 2018

Jan 30, 2019

SELL
$60.54 - $79.0 $364,753 - $475,975
-6,025 Reduced 36.31%
10,569 $661,000
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $577,866 - $639,804
-8,107 Reduced 32.82%
16,594 $1.28 Million
Q2 2018

Aug 15, 2018

BUY
$64.88 - $75.68 $43,469 - $50,705
670 Added 2.79%
24,701 $1.75 Million
Q1 2018

May 07, 2018

BUY
$72.84 - $88.8 $74,223 - $90,487
1,019 Added 4.43%
24,031 $1.81 Million
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $139,169 - $163,365
-1,956 Reduced 7.83%
23,012 $1.65 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $252,457 - $299,230
3,501 Added 16.31%
24,968 $2.02 Million
Q2 2017

Aug 14, 2017

BUY
N/A
21,467
21,467 $1.52 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.